AI Generated
May 9, 2026, 22:55
Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
Transfusion Evidence Library, shared a post on LinkedIn about a recent article by Al-Samkari H et al. published in NEJM, adding:
”New from the Transfusion Evidence Alert:
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.”
Title: Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
Authors: Hanny Al-Samkari, César Muñoz, Çağdaş Geredeli, Ioannis Korantzis, Bárbara González Astorga, Can Arslan, João F. Cordeiro Camargo, Franck Scotté , Gilberto Borges, Kai Wang, Martin Kuter, Gerald A. Soff
Stay updated on all scientific advances with Hemostasis Today.
Bárbara González Astorga
Çağdaş Geredeli
Can Arslan
César Muñoz
Franck Scotté
Gerald A. Soff
Gilberto Borges
Hanny Al-Samkari
Health
Hematology
Hemophilia
Hemostasis
Hemostasis News
Hemostasis Today
Ioannis Korantzis
João F. Cordeiro Camargo
Kai Wang
Martin Kuter
Medicine
thrombosis
Transfusion Evidence Library
-
May 9, 2026, 23:13Aakanksha A: Building a Community for Advances in ALL
-
May 9, 2026, 22:43Simon Ash: Gestational Thrombocytopenia and Maternal Risk at SOAPAM 2026
-
May 9, 2026, 22:18Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery
-
May 9, 2026, 22:12Muhammad Aasim Ali: Treatment Strategies for Chemotherapy-Induced Cytopenias
-
May 9, 2026, 16:38Joseph R. Shaw: Risk Stratification is Only Useful if It is Practical, Consistent, and Easy to Apply at the Bedside
-
May 9, 2026, 16:11Milad Abdalla: When 180,000 Becomes 45,000 – The EDTA Trap
-
May 9, 2026, 16:10Gertrud U. Rey: Describing the Mechanism That Causes VITT
-
May 9, 2026, 16:09Dima Shulkin: The Earliest Warning Sign of a Severe Heart Attack May Already Be in the CBC
-
May 9, 2026, 16:08Luisanna M. Sánchez: Selected for the ASH Clinical Research Training Institute